MedTrace Logo

Methylphenidate Effect on Humphrey Visual Fields

NCT02162381 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2018-04-11

No results posted yet for this study

Summary

Study will include adults with abnormal visual fields. Half of them will be given either methylphenidate 10mg 2 hours before repeating the visual field test. the rest will serve as controls. All Subjects will also have a complete eye examination, a short questionnaire and a questionnaire to screen for attention deficit disorder. The investigators will compare the visual field results between the 2 tests.

Conditions

  • Visual Field Tests

Interventions

DRUG

methylphenidate

a single dose of methylphenidate 10 mg to be taken orally in the morning

OTHER

guidance

subjects will be given an explanation and advice about how to perform well in visual field testing

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Omer Y Bialer, M.D. · Rabin Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2018-04-10
Completion
2018-04-10

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02162381 on ClinicalTrials.gov